+

WO1997019178A3 - Autoantigene Metallproteasen und Verfahren zur Diagnose von Autoimmunkrankheiten - Google Patents

Autoantigene Metallproteasen und Verfahren zur Diagnose von Autoimmunkrankheiten Download PDF

Info

Publication number
WO1997019178A3
WO1997019178A3 PCT/DE1996/002094 DE9602094W WO9719178A3 WO 1997019178 A3 WO1997019178 A3 WO 1997019178A3 DE 9602094 W DE9602094 W DE 9602094W WO 9719178 A3 WO9719178 A3 WO 9719178A3
Authority
WO
WIPO (PCT)
Prior art keywords
autoantigenic
polypeptide
autoimmune diseases
methods
diagnosing autoimmune
Prior art date
Application number
PCT/DE1996/002094
Other languages
English (en)
French (fr)
Other versions
WO1997019178A2 (de
Inventor
Ulrich Krawinkel
Simon Mauch
Radislav Sedlacek
Original Assignee
Univ Konstanz
Ulrich Krawinkel
Simon Mauch
Radislav Sedlacek
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Konstanz, Ulrich Krawinkel, Simon Mauch, Radislav Sedlacek filed Critical Univ Konstanz
Publication of WO1997019178A2 publication Critical patent/WO1997019178A2/de
Publication of WO1997019178A3 publication Critical patent/WO1997019178A3/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Rehabilitation Therapy (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Die vorliegende Erfindung betrifft Nukleinsäuren, die mindestens eine für ein Polypeptid kodierende Nukleinsäuresequenz enthalten, wobei das Polypeptid mindestens eine aus einer Metallprotease stammende autoantigene Determinante enthält, das Polypeptid selbst sowie gegen das Polypeptid gerichtete Antikörper und gegen das Polypeptid gerichtete spezifische Inhibitoren. Ferner betrifft die vorliegende Erfindung Verfahren und Kits zum Nachweis von autoantigenen Metallproteasen und von Autoimmunkrankheiten wie rheumatoide Arthritis.
PCT/DE1996/002094 1995-11-20 1996-11-04 Autoantigene metallproteasen und verfahren zur diagnose von autoimmunkrankheiten WO1997019178A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19543265A DE19543265A1 (de) 1995-11-20 1995-11-20 Autoantigene und Verfahren zur Diagnose von Autoimmunkrankheiten
DE19543265.7 1995-11-20

Publications (2)

Publication Number Publication Date
WO1997019178A2 WO1997019178A2 (de) 1997-05-29
WO1997019178A3 true WO1997019178A3 (de) 1997-09-25

Family

ID=7777951

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1996/002094 WO1997019178A2 (de) 1995-11-20 1996-11-04 Autoantigene metallproteasen und verfahren zur diagnose von autoimmunkrankheiten

Country Status (2)

Country Link
DE (1) DE19543265A1 (de)
WO (1) WO1997019178A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6566116B1 (en) 1996-04-25 2003-05-20 Takeda Chemical Industries, Ltd. Matrix metalloprotease
WO1998040475A1 (en) * 1997-03-11 1998-09-17 Abbott Laboratories Human matrix metalloprotease gene, proteins encoded therefrom and methods of using same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0522169A1 (de) * 1991-01-21 1993-01-13 Fuji Yakuhin Kogyo Kabushiki Kaisha Gegen menschliches stromelysin gerichteter monoklonaler antikörper und diagnoserheumatischr arthritis mittels enzym-immuntest
WO1994010208A1 (en) * 1992-10-29 1994-05-11 Miles Inc. Diagnostic assay for latent matrix metalloproteinase no. 9

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0685557B1 (de) * 1993-11-30 1998-08-12 Fuji Yakuhin Kogyo Kabushiki Kaisha Neue metalloprotease und kodierende dna dafür
EP0750672B1 (de) * 1994-03-17 2001-11-28 Max-Delbrück-Centrum Für Molekulare Medizin Dna-sequenzen für matrix-metallproteasen, ihre herstellung und verwendung

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0522169A1 (de) * 1991-01-21 1993-01-13 Fuji Yakuhin Kogyo Kabushiki Kaisha Gegen menschliches stromelysin gerichteter monoklonaler antikörper und diagnoserheumatischr arthritis mittels enzym-immuntest
WO1994010208A1 (en) * 1992-10-29 1994-05-11 Miles Inc. Diagnostic assay for latent matrix metalloproteinase no. 9

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
COSSINS J ET AL: "Identification of MMP-18, a putative novel human matrix metalloproteinase.", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 228 (2). 1996. 494-498. ISSN: 0006-291X, XP002036483 *
SIRUM K L ET AL: "CLONING OF THE GENES FOR HUMAN STROMELYSIN AND STROMELYSIN 2: DIFFERENTIAL EXPRESSION IN RHEUMATOID SYNOVIAL FIBROBLASTS", BIOCHEMISTRY, vol. 28, no. 22, 1989, pages 8691 - 8698, XP002029122 *

Also Published As

Publication number Publication date
DE19543265A1 (de) 1997-06-05
WO1997019178A2 (de) 1997-05-29

Similar Documents

Publication Publication Date Title
EP0621284A4 (de) PEPTIDE BESTEHEND AUS AMINOSÄURESEQUENZEN AUS ENTWEDER LIPOPROTEIN(a) ODER APOLIPOPROTEIN(a), ANTIKÖRPER, DIE DIESE AMINOSÄURESEQUENZEN ERKENNEN UND MESSVERFAHREN MIT DIESEN ANTIKÖRPERN.
WO2003050542A3 (en) Method of detecting autoantibodies from patients suffering from rheumatoid arthritis, a peptide and an assaykit
WO1999047656A3 (en) Nucleic acid binding proteins
CA2248140A1 (en) Assay and reagents for quantifying hbnp
GB2338711A8 (en) Identification and characterization of interactingmolecules
WO1996012189A3 (en) METHODS OF SCREENING FOR ULCERATIVE COLITIS AND CROHN'S DISEASE BY DETECTING VH3-15 AUTOANTIBODY AND pANCA
IL163066A (en) Ligands for the zcytor17 receptor
HK1059290A1 (en) Isolating cells expressing secreted proteins
CA2344642A1 (en) Characterising polypeptides through cleavage and mass spectrometry
WO1999057311A3 (en) Novel method for the identification of clones conferring a desired biological property from an expression library
WO1998022503A3 (en) Peptide derived from an antigen recognized by autoantibodies from patients with rheumatoid arthritis, antibody directed against said peptide, a combinatorial antigen, and a method of detecting auto-immune antibodies
MX9708791A (es) Gen de ataxia-telangiectasia y su organizacion genomica.
HU9601448D0 (en) Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
NZ296748A (en) Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods
WO2002031509A3 (en) Method for determining mass altering moiety in peptides
WO1998042827A3 (en) Gene encoding oxalate decarboxylase from aspergillus phoenicis
EP0253325A3 (de) Von Onkogenen abgeleitete Peptide
WO1997019178A3 (de) Autoantigene Metallproteasen und Verfahren zur Diagnose von Autoimmunkrankheiten
CA2129044A1 (en) Determination of binding affinity using magnetically-labeled binding members
WO1994024283A3 (en) A mammalian guanine nucleotide binding protein with an adp-rybosylation factor domain
WO1996040763A3 (en) Peptides for hiv-1 detection
WO1997035015A3 (de) Tyrosin-phosphatase-verwandtes protein
AU9437598A (en) Method and kit for identifying interactions between proteins or peptides
ITRM950434A0 (it) Polipeptide per la riparazione di informazione genetica, sequenza nucleotidica che codifica per esso e procedimento per la sua preparazione.
WO1998030687A3 (de) Srcr domäne-enthaltendes protein

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA GB JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 97519273

Format of ref document f/p: F

122 Ep: pct application non-entry in european phase
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载